Next Article in Journal
Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies
Next Article in Special Issue
Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide
Previous Article in Journal
Genetic Diversity and Differentiation of the Orange-Spotted Grouper (Epinephelus coioides) Between and Within Cultured Stocks and Wild Populations Inferred from Microsatellite DNA Analysis
Previous Article in Special Issue
A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles
Int. J. Mol. Sci. 2011, 12(7), 4395-4413; doi:10.3390/ijms12074395

Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel

1 School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China 2 St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
* Author to whom correspondence should be addressed.
Received: 27 April 2011 / Revised: 9 June 2011 / Accepted: 15 June 2011 / Published: 7 July 2011
(This article belongs to the Special Issue Bioactive Nanoparticles (special issue))
View Full-Text   |   Download PDF [468 KB, uploaded 19 June 2014]   |   Browse Figures


Anticancer drugs, such as paclitaxel (PTX), are indispensable for the treatment of a variety of malignancies. However, the application of most drugs is greatly limited by the low water solubility, poor permeability, or high efflux from cells. Nanoparticles have been widely investigated to enable drug delivery due to their low toxicity, sustained drug release, molecular targeting, and additional therapeutic and imaging functions. This review takes paclitaxel as an example and compares different nanoparticle-based delivery systems for their effectiveness in cancer chemotherapy.
Keywords: nanomaterials; anticancer drugs; paclitaxel; drug carrier; drug delivery nanomaterials; anticancer drugs; paclitaxel; drug carrier; drug delivery
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Liu, Y.; Zhang, B.; Yan, B. Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel. Int. J. Mol. Sci. 2011, 12, 4395-4413.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert